搜尋
Medicus Pharma Ltd
MDCX添加自選
0.275USD
+0.013+4.80%
收盤 07-31 16:00（美東）報價延遲15分鐘
11.01M總市值
虧損本益比TTM
關於 Medicus Pharma Ltd 公司
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. SkinJect Inc., a wholly owned subsidiary of the Company, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver a chemotherapeutic agent to eradicate tumors cells. It is conducting a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-003) in the United States and Europe. It has also commenced a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-004) in the UAE. Its subsidiary, Antev Limited, is a late clinical stage biotech company, developing Teverelix, a GnRH antagonist, as a first in market product for cardiovascular high-risk advanced prostate cancer patients and patients with first acute urinary retention relapse episodes due to enlarged prostate.
Medicus Pharma Ltd簡介
公司代碼MDCX
公司名稱Medicus Pharma Ltd
上市日期Oct 11, 2023
CEOBokhari (Raza)
員工數量12
證券類型Ordinary Share
年結日Oct 11
公司地址300 Conshohocken State Rd.
城市CONSHOHOCKEN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編19428
電話16105407515
網址https://medicuspharma.com/
公司代碼MDCX
上市日期Oct 11, 2023
CEOBokhari (Raza)
Medicus Pharma Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Raza Bokhari, M.D.
Dr. Raza Bokhari, M.D.
Executive Chairman, of the Board, Chief Executive Officer
Executive Chairman, of the Board, Chief Executive Officer
793.17K
--
Mr. Patrick J. Mahaffy
Mr. Patrick J. Mahaffy
Director
Director
35.44K
--
Ms. Carolyn F. Bonner
Ms. Carolyn F. Bonner
President, Chief Financial Officer
President, Chief Financial Officer
18.91K
--
Mr. William L. (Bill) Ashton
Mr. William L. (Bill) Ashton
Independent Director
Independent Director
1.25K
--
Mr. Andrew A. Smith
Mr. Andrew A. Smith
Chief Operating Officer
Chief Operating Officer
164.00
--
Dr. Faisal Mehmud, M.D.
Dr. Faisal Mehmud, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Edward J. Brennan, Jr., M.D.
Dr. Edward J. Brennan, Jr., M.D.
Chief Scientific Officer, Head of Research and Development Program
Chief Scientific Officer, Head of Research and Development Program
--
--
Dr. Larry R. Kaiser
Dr. Larry R. Kaiser
Independent Director
Independent Director
--
--
Mr. Robert J. Ciaruffoli, CPA
Mr. Robert J. Ciaruffoli, CPA
Lead Independent Director
Lead Independent Director
--
--
Mr. Frank W. Lavelle
Mr. Frank W. Lavelle
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Raza Bokhari, M.D.
Dr. Raza Bokhari, M.D.
Executive Chairman, of the Board, Chief Executive Officer
Executive Chairman, of the Board, Chief Executive Officer
793.17K
--
Mr. Patrick J. Mahaffy
Mr. Patrick J. Mahaffy
Director
Director
35.44K
--
Ms. Carolyn F. Bonner
Ms. Carolyn F. Bonner
President, Chief Financial Officer
President, Chief Financial Officer
18.91K
--
Mr. William L. (Bill) Ashton
Mr. William L. (Bill) Ashton
Independent Director
Independent Director
1.25K
--
Mr. Andrew A. Smith
Mr. Andrew A. Smith
Chief Operating Officer
Chief Operating Officer
164.00
--
Dr. Faisal Mehmud, M.D.
Dr. Faisal Mehmud, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
常見問題
Medicus Pharma Ltd的前五大股東是誰？
Medicus Pharma Ltd的前五大股東如下：Dr. Raza Bokhari, M.D.
有多少機構持有Medicus Pharma Ltd(MDCX)的股份？
截至2026Q1，共有38家機構持有Medicus Pharma Ltd的股份，合計持有的股份價值約為4.15M，占公司總股份的7.52% 。與2025Q4相比，機構持股有所增加，增幅為1672664.00。